Percutaneous Left Ventricular Assist Device (LVAD)

Related Conditions
TandemHeart LVADUW Health Heart and Vascular Care performed Wisconsin's first FDA-approved TandemHeart® percutaneous left ventricular assist device (LVAD) procedure in January 2004.
This small centrifugal pump can deliver 3.5 to 4.0 liters per minute of assisted cardiac output. Indications would include shock following heart attack, complications of balloon angioplasty and stenting, and left ventricular failure.
In situations when patients might be too ill to be transported, our team is able to travel to regional hospitals to implant the device locally prior to transfer to UW Hospital and Clinics.
Pioneering the Treatment